Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy

doi:10.4251/wjgo.v13.i12.2076

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 12

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4573)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

328

WORD

136

HTML

2846

Figures (1-1)

150

Sum=3460

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

302

Download

811

Sum=1113

Dec 15, 2021 (publication date) through Aug 23, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Oncol. Dec 15, 2021; 13(12): 2076-2087
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2076

Open in New Tab Full Size Figure Download Figure

Figure 1 Treatment strategy for intermediate stage hepatocellular carcinoma. HCC: Epatocellular carcinoma; MWA: Microwave ablation; ORR: Objective response rate; PFS: Progression-free survival; RFA: Radiofrequency ablation; TACE: Transcatheter arterial chemoembolization.

Citation: Sho T, Morikawa K, Kubo A, Tokuchi Y, Kitagataya T, Yamada R, Shigesawa T, Kimura M, Nakai M, Suda G, Natsuizaka M, Ogawa K, Sakamoto N. Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy. World J Gastrointest Oncol 2021; 13(12): 2076-2087
URL: https://www.wjgnet.com/1948-5204/full/v13/i12/2076.htm
DOI: https://dx.doi.org/10.4251/wjgo.v13.i12.2076